1 not yet recruiting, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Withdrawn 1 |
Follow Tenecteplase: new trials by email Literature Review of Tenecteplase trials Research Report on Tenecteplase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg) - Acute Ischemic Stroke | Phase 1 | Not yet recruiting | Memorial Hermann Health System | 20 | 2025-07-01 | 2025-06-05 |
| Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study Tenecteplase - Acute Respiratory Distress Syndrome | Phase 1 | Withdrawn | Wake Forest University Health Sciences | 2007-02-01 | 2024-10-16 |
Ischemic Stroke (1) · Respiratory Distress Syndrome (1) · Stroke (1)
Memorial Hermann Health System (1) · Wake Forest University Health Sciences (1)
United States (2)
Debra M Kitchens, RN, CEN (1) · Dennis W. Ashley, MD, FACS (1)